MetaCap

Elevance Health Earnings

NYSE: ELVHealth CareMedical SpecialitiesUSD

412.70+11.76 (+2.93%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Oct 21, 2026

Before market open

Fiscal period

Sep/2026

EPS estimate

$4.66

Elevance Health earnings summary

Elevance Health is scheduled to report Sep/2026 earnings on Oct 21, 2026 before the market opens, with analysts expecting EPS of $4.66. In its most recent report on Jul 15, 2026 (Q2 2026), ELV posted EPS of $6.71. Revenue for the quarter was $50.47 billion.

Quarterly EPS is down 13.1% from the same quarter a year earlier. Across the last 16 reports, ELV shares moved an average of 3.6% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.

Summary generated from market data by MetaCap's automated system. Methodology

ELV earnings history

Elevance Health reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 15, 2026—$6.71—+1.2%
Apr 22, 2026—$8.00—+8.1%
Feb 6, 2026—$2.56—+2.3%
Oct 21, 2025—$5.32—-7.3%
Jul 17, 2025—$7.72—+4.3%
Apr 22, 2025—$9.61—-2.8%
Feb 20, 2025—$1.88—+3.1%
Oct 17, 2024—$4.36—-1.3%
Jul 17, 2024—$9.85—+5.5%
Apr 18, 2024—$9.59—+1.1%
Feb 21, 2024—$3.68—-2.9%
Oct 18, 2023—$5.45—-2.7%
Jul 19, 2023—$7.79—-1.9%
Apr 19, 2023—$8.30—+4.0%
Feb 15, 2023—$3.61—-3.4%
Oct 19, 2022—$6.62—+6.4%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related